Table 2.
Number of "very early" HCC patients treated in adherence with the AASLD indications.
| ACTUAL TREATMENT | ||||||
|---|---|---|---|---|---|---|
| AASLD INDICATIONS | RESECTION | OLTx | PEI/RFTA | TACE | BSC | |
| RESECTION | 5 (13%) | 1(2%) | 24(59%) | 10(24%) | 1(2%) | |
| OLTx | 2(33%) | 2(33%) | - | 2(33%) | - | |
| PEI or RFTA | 1(7%) | - | 6(46%) | 4(31%) | 2(16%) | |
OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation;
PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care
AASLD indications for treatment are reported in rows; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication.
The adherence to AASLD indication was evaluated when all data were available (60/65 pts – 91%).